Just a quickie (not much info): According to a recent interview, Civamide is supposed to enter Phase II clinical trials later this year or early 2009. A press release back in fall of 2007 suggested this was further along, so I had it in the Phase III section of our Clinical Trial Roster but I've now corrected that.

Interview with OPKO Health VP Samuel Reich
Sept 8, 2008

We have a drug called civamide that we are developing. It's a clinical stage drug and we are entering a Phase II trial later this year or early 2009. The clinical stage drug is for dry eye and dry eye is becoming an increasingly big problem and represents a very large market. We see dry eye as an unmet medical need and an important area of focus for OPKO.